Revance Stock Rises as Teoxane Begins Talks for Potential Higher Acquisition Offer
Daily NewsInvesting.com -- Revance Therapeutics' shares rose 3% in pre-market trading on Wednesday following news that it would begin discussions about a potential superior...
Read More